proxyvotesnow.com

Home › Asset managers › Compare 2024-2025 › BlackRock vs American Century

BlackRock vs American Century: how alike they voted, 2024-2025

85.7% When both took a single position, they voted the same way on 85.7% of 15,908 items (13,640 the same, 2,268 different). 373 items where at least one of them split its funds are listed separately below. Both voted on 16,281 items in all.

BlackRock 2024-2025 · American Century 2024-2025 · Download the item list (CSV)

By who put the item on the ballot. “Same position” = Same / (Same + Differ); split items are not in it. “Fund-level” is a second view over all common items: the chance that a fund of each manager, picked at random, voted the same way, which gives partial credit where a manager split.
Common itemsSame DifferSplit (not in %)Same position Fund-level
All ballot items 16,28113,6402,268 37385.7%84.9%
Board proposals 12,3149,9942,043 27783.0%82.2%
E&S shareholder proposals 2341971 3699.5%96.1%
Other items 3,7333,449224 6093.9%93.1%

Where they did not vote alike

Everything Voted differently Split votes

All ballot items Board proposals E&S shareholder proposals Other items

2,320 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.

CompanyMeetingProposalOn the ballot from Board recommendedBlackRockAmerican Century
HUB GROUP INC. May 13, 2025 Advisory vote to approve executive compensation.
Say-on-Pay
Board For FOR
28 funds
AGAINST
8 funds
HUBBELL INC. May 6, 2025 To approve the Hubbell Incorporated Incentive Award Plan.
Compensation
Board For FOR
44 funds
AGAINST
12 funds
HUBBELL INC. May 6, 2025 To approve, by advisory vote, the compensation of our Named Executive Officers as presented in the 2025 Proxy Statement.
Say-on-Pay
Board For FOR
64 funds
AGAINST
13 funds
HUNTSMAN CORP. April 30, 2025 Advisory vote to approve named executive officer compensation.
Say-on-Pay
Board For FOR
41 funds
AGAINST
7 funds
HUNTSMAN CORP. April 30, 2025 Approval of the Huntsman Corporation 2025 Stock Incentive Plan.
Compensation
Board For FOR
25 funds
AGAINST
6 funds
HURCO COMPANIES INC. March 13, 2025 To approve amendments to the Amended and Restated Hurco Companies, Inc. 2016 Equity Incentive Plan.
Compensation
Board For FOR
1 fund
AGAINST
1 fund
HURON CONSULTING GROUP INC. May 9, 2025 To approve an amendment to the Company's Amended and Restated 2012 Omnibus Incentive Plan.
Compensation
Board For FOR
14 funds
AGAINST
3 funds
HUSQVARNA AB April 29, 2025 Reelect Torbjorn Loof as Director
Director Elections
Board For AGAINST
7 funds
FOR
4 funds
HUT 8 CORP. June 18, 2025 To approve an amendment to the Hut 8 Corp. 2023 Omnibus Incentive Plan.
Compensation
Board For FOR
15 funds
AGAINST
3 funds
HUT 8 CORP. June 18, 2025 To approve, on an advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
26 funds
AGAINST
4 funds
HYSTER-YALE INC. May 13, 2025 To approve, on an advisory basis, the Company's Named Executive Officer compensation
Say-on-Pay
Board For FOR
20 funds
AGAINST
7 funds
I3 VERTICALS INC. February 25, 2025 To consider and act upon a non-binding, advisory vote to approve the compensation of the Company's named executive officers as disclosed in the Proxy Statement.
Say-on-Pay
Board For FOR
17 funds
AGAINST
3 funds
IAC INC. June 18, 2025 To approve a non-binding advisory vote on IAC's 2024 executive compensation.
Say-on-Pay
Board For FOR
31 funds
AGAINST
3 funds
ICHOR HOLDINGS LTD. May 14, 2025 Advisory approval of the compensation of our named executive officers.
Say-on-Pay
Board For FOR
29 funds
AGAINST
10 funds
ICHOR HOLDINGS LTD. May 14, 2025 To approve the adoption of the Ichor Holdings, Ltd. 2025 Omnibus Incentive Plan.
Compensation
Board For FOR
17 funds
AGAINST
9 funds
ICU MEDICAL INC. May 13, 2025 To approve an amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan.
Compensation
Board For FOR
15 funds
AGAINST
1 fund
IDACORP INC. May 15, 2025 Advisory resolution to approve our executive compensation.
Say-on-Pay
Board For FOR
45 funds
AGAINST
5 funds
IDACORP INC. May 15, 2025 Approve the IDACORP, Inc. 2000 Long-Term Incentive and Compensation Plan, as amended and restated, including the authorization of 1,100,000 additional shares.
Compensation
Board For FOR
31 funds
AGAINST
4 funds
IDEX CORP. May 8, 2025 Advisory vote to approve named executive officer compensation.
Say-on-Pay
Board For FOR
57 funds
AGAINST
6 funds
IDORSIA LTD May 28, 2025 APPROVE CREATION OF CAPITAL BAND WITHIN THE UPPER LIMIT OF CHF 16.9 MILLION AND THE LOWER LIMIT OF CHF 5.6 MILLION WITH OR WITHOUT EXCLUSION OF PREEMPTIVE RIGHTS
Capital Structure
Board For FOR
1 fund
AGAINST
2 funds
IDT CORP. December 12, 2024 Advisory vote on executive compensation.
Say-on-Pay
Board For FOR
25 funds
AGAINST
5 funds
IES HOLDINGS INC. February 20, 2025 ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.
Say-on-Pay
Board For FOR
25 funds
AGAINST
6 funds
IES HOLDINGS INC. February 20, 2025 APPROVAL OF THE COMPANY'S AMENDED AND RESTATED 2006 EQUITY INCENTIVE PLAN.
Compensation
Board For FOR
13 funds
AGAINST
5 funds
ILLUMINA May 21, 2025 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.
Say-on-Pay
Board Not determined FOR
59 funds
AGAINST
8 funds
IMAX CORP. June 11, 2025 Advisory Vote on Named Executive Officer Compensation Approval, on an advisory basis, of the compensation of the Company's Named Executive Officers as set forth in the accompanying Proxy Circular and Proxy Statement.
Say-on-Pay
Board For FOR
22 funds
AGAINST
6 funds
IMMUNOVANT INC August 12, 2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
26 funds
AGAINST
2 funds
IMPINJ INC. June 5, 2025 To approve, on an advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
31 funds
AGAINST
6 funds
INCYTE CORP. June 10, 2025 Approve amendments of the Company's Amended and Restated 2010 Stock Incentive Plan.
Compensation
Board For FOR
56 funds
AGAINST
7 funds
INCYTE CORP. June 10, 2025 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
76 funds
AGAINST
8 funds
INDEPENDENT BANK CORP. May 15, 2025 Approve, on an advisory basis, the compensation of our named executive officers
Say-on-Pay
Board For FOR
26 funds
AGAINST
8 funds
INDUSTRIVAERDEN AB April 10, 2025 REELECT KATARINA MARTINSON AS DIRECTOR
Director Elections
Board For FOR
22 funds
AGAINST
3 funds
INDUSTRIVAERDEN AB April 10, 2025 REELECT PAR BOMAN AS DIRECTOR
Director Elections
Board For FOR
22 funds
AGAINST
3 funds
INDUTRADE AB April 3, 2025 REELECT ANDERS JERNHALL AS DIRECTOR
Director Elections
Board For FOR
17 funds
AGAINST
4 funds
INFUSYSTEM HOLDINGS INC. May 15, 2025 Approval of an amendment increasing the number of shares reserved under the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan.
Compensation
Board For FOR
6 funds
AGAINST
4 funds
INGEVITY CORP. April 30, 2025 Advisory vote on compensation of our Named Executive Officers (Say-on-Pay).
Say-on-Pay
Board Contested FOR
29 funds
AGAINST
8 funds
INGEVITY CORP. April 30, 2025 Approve the Ingevity Corporation 2025 Omnibus Incentive Plan
Compensation
Board Contested FOR
16 funds
AGAINST
7 funds
INGREDION INC. May 21, 2025 To approve, by advisory vote, the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
59 funds
AGAINST
12 funds
INMUNE BIO INC. June 10, 2025 To approve the Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan.
Compensation
Board For FOR
5 funds
AGAINST
1 fund
INMUNE BIO INC. June 10, 2025 To approve, by non-binding advisory vote, the resolution approving named executive officer compensation.
Say-on-Pay
Board For FOR
8 funds
AGAINST
2 funds
INNODATA INC. June 5, 2025 Approval on a non-binding, advisory basis the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
15 funds
AGAINST
4 funds
INNOVATIVE INDUSTRIAL PROPERTIES INC. June 11, 2025 Approval on a non-binding advisory basis of the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
32 funds
AGAINST
3 funds
INNOVEX INTERNATIONAL INC. May 14, 2025 To adopt the Company's 2025 Long-Term Incentive Plan.
Compensation
Board For FOR
14 funds
AGAINST
5 funds
INNOVEX INTERNATIONAL INC. May 14, 2025 To conduct a non-binding advisory vote to approve the Company's compensation of its named executive officers.
Say-on-Pay
Board For FOR
25 funds
AGAINST
6 funds
INNOVIVA INC May 19, 2025 Approval of a non-binding advisory resolution regarding executive compensation.
Say-on-Pay
Board For FOR
31 funds
AGAINST
8 funds
INOGEN INC. May 14, 2025 To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan.
Compensation
Board For FOR
9 funds
AGAINST
5 funds
INOGEN INC. May 14, 2025 To approve, on an advisory and non-binding basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
14 funds
AGAINST
6 funds
INOTIV INC. March 13, 2025 Approve an amendment to the Inotiv, Inc. 2024 Equity Incentive Plan
Compensation
Board For FOR
1 fund
AGAINST
2 funds
INOTIV INC. March 13, 2025 Say on Pay - An advisory vote on the approval of the compensation of the Company's named executive officers
Say-on-Pay
Board For FOR
3 funds
AGAINST
3 funds
INOVIO PHARMACEUTICALS INC. May 20, 2025 To approve an amendment and restatement of our 2023 Omnibus Incentive Plan.
Compensation
Board For FOR
6 funds
AGAINST
2 funds
INSIGHT EN May 13, 2025 Advisory vote (non-binding) to approve named executive officer compensation.
Say-on-Pay
Board Not determined FOR
37 funds
AGAINST
11 funds
INSMED INC. May 15, 2025 Approval of Amendment No. 2 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.
Compensation
Board For FOR
21 funds
AGAINST
8 funds
INSPERITY INC. May 20, 2025 Approval of the First Amendment to the Insperity, Inc. Incentive Plan
Compensation
Board For FOR
21 funds
AGAINST
4 funds
INSTALCO AB May 6, 2025 Reelect Camilla Oberg as Director
Director Elections
Board For AGAINST
9 funds
FOR
3 funds
INSTALCO AB May 6, 2025 Reelect Carina Edblad as Director
Director Elections
Board For AGAINST
9 funds
FOR
3 funds
INSTALCO AB May 6, 2025 Reelect Carina Qvarngard as Director
Director Elections
Board For AGAINST
9 funds
FOR
3 funds
INSTALCO AB May 6, 2025 Reelect Per Leopoldsson as Director
Director Elections
Board For AGAINST
9 funds
FOR
3 funds
INSTALCO AB May 6, 2025 Reelect Ulf Wretskog as Director
Director Elections
Board For AGAINST
9 funds
FOR
3 funds
INSULET May 22, 2025 To approve the Insulet Corporation 2025 Stock Option and Incentive Plan.
Compensation
Board For FOR
40 funds
AGAINST
12 funds
INSULET May 22, 2025 To approve, on a non-binding, advisory basis, the compensation of certain executive officers.
Say-on-Pay
Board For FOR
60 funds
AGAINST
13 funds
INTEGER HOLDINGS CORP. May 21, 2025 To approve, on an advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
28 funds
AGAINST
7 funds
INTEGRA LIFESCIENCES HOLDINGS CORP. May 9, 2025 To approve Amendment No. 2 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan.
Compensation
Board For FOR
15 funds
AGAINST
6 funds
INTEL CORP. May 6, 2025 Advisory vote on executive compensation (Say-On-Pay).
Say-on-Pay
Board For FOR
71 funds
AGAINST
7 funds
INTEL CORP. May 6, 2025 Approval of amendment and restatement of the 2006 Equity Incentive Plan.
Compensation
Board For FOR
53 funds
AGAINST
6 funds
INTELLIA THERAPEUTICS INC. June 11, 2025 Approval of the Intellia Therapeutics, Inc. 2025 Equity Incentive Plan.
Compensation
Board For FOR
18 funds
AGAINST
4 funds
INTELLIA THERAPEUTICS INC. June 11, 2025 Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOs").
Say-on-Pay
Board For FOR
31 funds
AGAINST
5 funds
INTER PARFUMS INC. September 17, 2024 To vote for the advisory resolution to approve executive compensation.
Say-on-Pay
Board For FOR
27 funds
AGAINST
7 funds
INTERDIGITAL INC. June 11, 2025 Adoption and approval of the 2025 Equity Incentive Plan.
Compensation
Board For FOR
21 funds
AGAINST
7 funds
INTERDIGITAL INC. June 11, 2025 Advisory resolution to approve executive compensation.
Say-on-Pay
Board For FOR
36 funds
AGAINST
8 funds
INTERFACE INC. May 15, 2025 Approval, on an advisory basis, of executive compensation.
Say-on-Pay
Board For FOR
33 funds
AGAINST
8 funds
INTERNATIONAL BANCSHARES CORP. May 19, 2025 PROPOSAL TO CONSIDER AND VOTE ON a non-binding advisory resolution to approve the compensation of the Company's named executives as described in the Compensation Discussion and Analysis and the tabular disclosure regarding executive compensation in the Proxy Statement.
Say-on-Pay
Board For FOR
32 funds
AGAINST
10 funds
INTERNATIONAL MONEY EXPRESS INC. June 20, 2025 Approval of a non-binding advisory resolution regarding the compensation of the named executive officers of International Money Express, Inc.
Say-on-Pay
Board For FOR
19 funds
AGAINST
7 funds
INTERNATIONAL MONEY EXPRESS INC. June 20, 2025 Approval of the Amended and Restated International Money Express, Inc. 2020 Omnibus Equity Compensation Plan.
Compensation
Board For FOR
10 funds
AGAINST
6 funds
INTERNATIONAL SEAWAYS INC. June 10, 2025 Approval of the International Seaways, Inc. 2025 Management Incentive Compensation Plan.
Compensation
Board For FOR
17 funds
AGAINST
7 funds
INTERROLL HOLDING AG June 6, 2025 Reelect Ingo Specht as Director
Director Elections
Board For FOR
7 funds
AGAINST
5 funds
INTERROLL HOLDING AG June 6, 2025 Reelect Stefano Mercorio as Director
Director Elections
Board For FOR
7 funds
AGAINST
5 funds
INTRA-CELLULAR THERAPIES INC. March 27, 2025 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.
Say-on-Pay
Board For FOR
39 funds
AGAINST
5 funds
INVESTORS TITLE CO. May 21, 2025 Advisory proposal to approve named executive officer compensation.
Say-on-Pay
Board For FOR
14 funds
AGAINST
7 funds
INWIDO AB May 15, 2025 Reelect Per Bertland as Board Chair
Director Elections
Board For AGAINST
6 funds
FOR
4 funds
INWIDO AB May 15, 2025 Reelect Per Bertland as Director
Director Elections
Board For AGAINST
6 funds
FOR
4 funds
IONIS PHARMACEUTICALS INC. June 5, 2025 To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 4,000,000 shares to an aggregate of 42,500,000 shares.
Compensation
Board For FOR
32 funds
AGAINST
2 funds
IOVANCE BIOTHERAPEUTICS INC. June 10, 2025 To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 12,500,000 shares.
Compensation
Board For FOR
15 funds
AGAINST
3 funds
IPG PHOTONICS CORP. May 20, 2025 Approval of the IPG Photonics Corporation 2025 Incentive Compensation Plan
Compensation
Board For FOR
20 funds
AGAINST
7 funds
IRADIMED CORP. June 19, 2025 To approve, on a non-binding advisory basis, the 2024 compensation of the named executive officers.
Say-on-Pay
Board For FOR
24 funds
AGAINST
4 funds
IRIDIUM COMMUNICATIONS INC. May 14, 2025 To approve the Iridium Communications Inc. Amended and Restated 2015 Equity Incentive Plan.
Compensation
Board For FOR
32 funds
AGAINST
6 funds
IRIDIUM COMMUNICATIONS INC. May 14, 2025 To approve, on an advisory basis, the compensation of our named executive officers.
Say-on-Pay
Board For FOR
48 funds
AGAINST
7 funds
IRON MOUNTAIN INC. May 29, 2025 The approval of an amendment to the Iron Mountain Incorporated 2014 Stock and Cash Incentive Plan as described in the Iron Mountain Incorporated Proxy Statement.
Compensation
Board For FOR
62 funds
AGAINST
8 funds
ISRACARD LTD July 11, 2024 APPROVE GRANT OF UNREGISTERED OPTIONS TO RAN OZ, CEO
Compensation
Board For FOR
19 funds
AGAINST
6 funds
ISRAEL CORP. LTD. July 29, 2024 Reappoint Somekh Chaikin (KPMG) as Auditors and Authorize Board to Fix Their Remuneration
Audit-related
Board For ABSTAIN
6 funds
AGAINST
6 funds
ISRAEL CORP. LTD. July 29, 2024 Reelect Yair Caspi as Director and Approve His Remuneration
Director Elections
Board For AGAINST
6 funds
FOR
6 funds
ISRAEL DISCOUNT BANK LTD. November 28, 2024 ELECT KEREN KIBOVICH AS DIRECTOR
Director Elections
Board For ABSTAIN
17 funds
FOR
5 funds
ISRAEL DISCOUNT BANK LTD. November 28, 2024 ELECT REUVEN ADLER AS DIRECTOR
Director Elections
Board For FOR
17 funds
ABSTAIN
5 funds
ISS A/S April 11, 2025 Authorize Share Repurchase Program
Capital Structure
Board For FOR
9 funds
AGAINST
2 funds
ITRON INC. May 8, 2025 Proposal to approve the advisory (non-binding) resolution relating to executive compensation.
Say-on-Pay
Board For FOR
35 funds
AGAINST
2 funds
ITT INC. May 21, 2025 Approval of a non-binding advisory vote on executive compensation
Say-on-Pay
Board For FOR
47 funds
AGAINST
6 funds
IVANHOE ELECTRIC INC. June 5, 2025 Non Binding, Advisory Vote to Approve Executive Compensation.
Say-on-Pay
Board For FOR
23 funds
AGAINST
2 funds
J.JILL INC. June 3, 2025 To approve the J.Jill, Inc. Amended & Restated 2017 Omnibus Equity Incentive Plan.
Compensation
Board For FOR
6 funds
AGAINST
1 fund
J.JILL INC. June 3, 2025 To approve, on an advisory basis, the compensation of the Company's named executive officers.
Say-on-Pay
Board For FOR
10 funds
AGAINST
2 funds
J.M. AB April 9, 2025 REELECT LIIA NOU AS DIRECTOR
Director Elections
Board For AGAINST
7 funds
FOR
6 funds
JACKSON FINANCIAL INC. May 22, 2025 Non-binding, Advisory Vote to approve executive compensation
Say-on-Pay
Board For FOR
27 funds
AGAINST
8 funds
JAMES RIVER GROUP HOLDINGS LTD. October 24, 2024 To approve the amendment of the James River Group Holdings, Ltd. 2014 Long-Term Incentive Plan.
Compensation
Board For FOR
10 funds
AGAINST
7 funds

← Previous Page 10 of 24 Next →

← All 20 managers, 2024-2025

How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.